Accession Number: | 0001209191-20-007067 |
Date: | 2020-02-03 |
Issuer: | CHEMOCENTRYX, INC. (CCXI) |
Original Submission Date: |
KANAYA SUSAN M
C/O CHEMOCENTRYX, INC.
850 MAUDE AVENUE
MOUNTAIN VIEW, CA 94043
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-02-03 | M | 3,837 | a | $14.31 | 98,017 | indirect | ||
COMMON STOCK | 2020-02-03 | S | 3,837 | d | $44.91 | 94,180 | indirect | ||
COMMON STOCK | 2020-02-04 | M | 99,617 | a | $14.31 | 193,797 | indirect | ||
COMMON STOCK | 2020-02-04 | S | 99,617 | d | $45.10 | 94,180 | indirect | ||
COMMON STOCK | 2020-02-03 | 0 | $0.00 | 91,317 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 14.31 | 2020-02-03 | deemed execution date | M | 3,837 (d) | 2022-07-24 | common stock 3,837 | $14.31 | 99,617 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 14.31 | 2020-02-04 | deemed execution date | M | 99,617 (d) | 2022-07-24 | common stock 99,617 | $14.31 | 0 | direct |
ID | footnote |
---|---|
f1 | the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person. |
f2 | reflects the weighted average sale price of the sales sold. the shares were sold in multiple trades at prices ranging from $44.90 to $44.94 per share. the reporting person will provide to the sec staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. |
f3 | reflects the weighted average sale price of the sales sold. the shares were sold in multiple trades at prices ranging from $44.90 to $45.59 per share. the reporting person will provide to the sec staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. |
f4 | as of february 3, 2020, and prior to this transaction, the exercised options were fully vested. |
f5 | not applicable. |